Table 3.
Respiratory disease related morbidity in Milos compared to Oinofita.
| Disease | Allergic rhinitis | Pneumonia | Asthma | Bronchiectasis | Chronic obstructive pulmonary disease (COPD.) | Respiratory failure | Cancer of Lung, trachea and bronchus |
|---|---|---|---|---|---|---|---|
| ICD9 | 477 | 480–486 | 493 | 494 | 496 | 518.81–518.84 | 162 |
| Milos% (N = 269) | 5.2 (14) | 5.9 (16) | 9.7 (26) | 0.7 (2) | 4.1 (11) | 0.4 (1) | 0.4 (1) |
| Oinofita% (N = 1,811) | 2.3 (41) | 1.0 (19) | 6.4 (115) | 0.1 (1) | 1.9 (35) | 0.4 (8) | 0.3 (5) |
| Chi-square test (p-value) | 0.005 | <0.001 | 0.044 | 0.006 | 0.025 | 0.870 | 0.785 |
| Fischer’s exact test (p-value) | 0.012 | <0.001 | 0.051 | 0.046 | 0.041 | 1.000 | 0.565 |
| OR (CI) | 2.37 (1.27–4.41) | 5.97 (3.03–11.75) | 1.58 (1.01–2.47) | 13.56 (1.23–150.04) | 2.16 (1.09–4.31) | 0.84 (0.11–6.75) | 1.35 (0.16–11.58) |
| OR (CI) and p-value controlling for gender, age and smoking (logistic regression) | 2.24 (1.20–4.19) | 5.47 (2.73–10.97) | 1.49 (0.95–2.34) | 12.47 (1.09–143.05) | 2.28 (1.11–4.66) | 0.83 (0.10–6.74) | 1.37 (0.16–11.99) |
| 0.011 | <0.001 | 0.082 | 0.043 | 0.024 | 0.858 | 0.774 |